Fresenius SE & Co. KGaA
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FSNUF research report →
Companywww.fresenius.com
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.
- CEO
- Michael Sen
- IPO
- 2012
- Employees
- 175,202
- HQ
- Bad Homburg vor der Höhe, DE
Price Chart
Valuation
- Market Cap
- $30.61B
- P/E
- 15.33
- P/S
- 0.98
- P/B
- 1.14
- EV/EBITDA
- 9.81
- Div Yield
- 2.49%
Profitability
- Gross Margin
- 25.25%
- Op Margin
- 9.45%
- Net Margin
- 6.38%
- ROE
- 7.76%
- ROIC
- 4.54%
Growth & Income
- Revenue
- $22.86B · 4.72%
- Net Income
- $1.26B · 168.26%
- EPS
- $2.25 · 167.86%
- Op Income
- $2.18B
- FCF YoY
- -21.42%
Performance & Tape
- 52W High
- $58.16
- 52W Low
- $37.73
- 50D MA
- $54.35
- 200D MA
- $54.65
- Beta
- 0.86
- Avg Volume
- 18
Get TickerSpark's AI analysis on FSNUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FSNUF Coverage
We haven't published any research on FSNUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FSNUF Report →